Endovia Health Sciences (EDVA) Income from Continuing Operations (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.44 Bn | 133.58 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 86.65 Bn | 78.66 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 65.10 Bn | 59.92 Bn | 1.37 Bn | 600.00 Mn |
| 4 | Moderna | 57.10 Bn | 51.97 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.13 Bn | 27.30 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -2.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.14 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Sep 30, 2025 | -9.86 Mn |
| Jun 30, 2025 | -8.36 Mn |
| Mar 31, 2025 | -3.28 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -3.56 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -3.78 Mn |
| Dec 31, 2023 | -4.58 Mn |
| Sep 30, 2023 | -4.32 Mn |
| Jun 30, 2023 | -4.22 Mn |
| Mar 31, 2023 | -3.45 Mn |
| Dec 31, 2022 | -4.79 Mn |
| Sep 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -5.83 Mn |
| Mar 31, 2022 | -5.68 Mn |
| Dec 31, 2021 | -6.25 Mn |
| Sep 30, 2021 | -12.17 Mn |